Rejected at 2:08 a.m. Nov, 01, 2023 ] by Ahmed7
Author: jprasadh
Related Note: 1497203445193
Rationale for change

mnemonic

Rejection reason

unpopular

Extra Extra
Text
Daclizumab is contraindicated in patients with {{c1::liver}} impairment
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Transplant Rejection: Biologic Immunotherapy
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::General-Immunotherapy #AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Daclizumab #AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::08_Biologic_Immunotherapy